Nova Leap Health Corp. (TSXV:NLH)

Nova Leap Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	31.47	25.76	26.18	28.21	21.28
Revenue Growth (YoY)	22.15%	-1.60%	-7.18%	32.55%	22.93%
Cost of Revenue	18.98	15.87	16.41	18.23	14.07
Gross Profit	12.48	9.89	9.77	9.98	7.21
Selling, General & Admin	10.44	8.33	8.29	9.32	7.21
Depreciation & Amortization Expenses	0.83	0.58	0.89	1.36	0.86
Other Operating Expenses	0.11	0.11	0.13	0.36	0.37
Total Operating Expenses	11.38	9.02	9.31	11.04	8.44
Operating Income	-1.11	-0.86	-0.46	1.06	1.23
Interest Expense	-0.35	-0.11	-0.14	-0.27	-0.4
Other Non-Operating Income (Expense)	-0.89	1.06	-1.68	0.13	4.11
Total Non-Operating Income (Expense)	-1.24	0.95	-1.83	-0.14	3.7
Pretax Income	-0.13	1.81	-1.37	-1.21	2.47
Provision for Income Taxes	0.26	0.23	-0.09	-0.51	-0.32
Net Income	-0.19	1.38	-1.05	-0.84	1.76
Net Income to Common	-0.19	1.38	-1.05	-0.84	1.76
Net Income Growth	-	-	-	-	40.15%
Shares Outstanding (Basic)	87	86	86	81	74
Shares Outstanding (Diluted)	87	87	86	81	78
Shares Change (YoY)	0.60%	0.68%	5.83%	4.90%	16.89%
EPS (Basic)	-0.00	0.02	-0.01	-0.01	0.02
EPS (Diluted)	-0.00	0.02	-0.01	-0.01	0.02
Free Cash Flow	1.56	1.36	2.13	0.95	2.18
Free Cash Flow Growth	14.19%	-35.91%	123.97%	-56.44%	-27.47%
Free Cash Flow Per Share	0.02	0.02	0.02	0.01	0.03
Gross Margin	39.67%	38.38%	37.31%	35.37%	33.89%
Operating Margin	-3.51%	-3.35%	-1.76%	3.77%	5.79%
Profit Margin	-0.60%	5.35%	-4.03%	-2.96%	8.27%
FCF Margin	4.95%	5.29%	8.12%	3.37%	10.24%
EBITDA	-0.27	-0.28	0.42	2.42	2.09
EBITDA Margin	-0.87%	-1.09%	1.62%	8.57%	9.84%
EBIT	-1.11	-0.86	-0.46	1.06	1.23
EBIT Margin	-3.51%	-3.35%	-1.76%	3.77%	5.79%
Effective Tax Rate	-198.89%	12.45%	6.68%	42.35%	-13.07%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.